One of the tumor-suppressor genes frequently mutated in MPM is NF2 and NF2-null cells were shown to be sensitive to growth-inhibitory effects of rapamycin6 via mechanisms involving PI3K signaling-independent mTORC1 activation. This evidence concerns the gene NF2 and neoplasm.